tiprankstipranks
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
UK Market
SBTX
SkinBioTherapeutics
RESEARCH TOOLSreports

SkinBioTherapeutics (SBTX) Ratios

24 Followers

SkinBioTherapeutics Ratios

GB:SBTX's free cash flow for Q4 2024 was £0.60. For the 2024 fiscal year, GB:SBTX's free cash flow was decreased by £ and operating cash flow was £0.13. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
 4.84 4.84 0.93 3.25 4.58
Quick Ratio
 4.29 4.29 0.66 3.19 4.34
Cash Ratio
 3.25 3.25 0.44 2.48 3.55
Solvency Ratio
 -0.11 -0.10 -1.20 -4.66 -4.53
Operating Cash Flow Ratio
 -0.88 -0.88 -1.51 -4.99 -5.25
Short-Term Operating Cash Flow Coverage
 -11.58 0.00 -3.68 -85.20 84.03
Net Current Asset Value
£ 4.40M£ 4.40M£ -573.77K£ 1.12M£ 1.72M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.08 0.16 0.04 0.04
Debt-to-Equity Ratio
 0.11 0.11 0.28 0.05 0.05
Debt-to-Capital Ratio
 0.10 0.10 0.22 0.05 0.05
Long-Term Debt-to-Capital Ratio
 0.06 0.06 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.29 1.76 1.30 1.25
Debt Service Coverage Ratio
 -1.00 -1.93 -3.35 -69.67 126.99
Interest Coverage Ratio
 -12.22 -8.99 -56.52 -337.54 -294.24
Debt to Market Cap
 0.03 0.02 0.04 <0.01 >-0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 16.96 19.26 >-0.01 0.41 0.57
Profitability Margins
Gross Profit Margin
58.33%58.33%56.50%64.51%60.64%
EBIT Margin
-13.44%-13.43%-239.62%-2271.26%-3988.83%
EBITDA Margin
-4.81%-4.24%-225.14%-2237.79%-3949.14%
Operating Profit Margin
-24.22%-17.83%-240.28%-2271.26%-3988.83%
Pretax Profit Margin
-15.41%-15.42%-243.92%-2277.98%-4002.38%
Net Profit Margin
-15.01%-15.01%-237.88%-2146.91%-3735.37%
Continuous Operations Profit Margin
-15.01%-15.01%-237.88%-2146.91%-3735.37%
Net Income Per EBT
97.39%97.36%97.52%94.25%93.33%
EBT Per EBIT
63.62%86.49%101.51%100.30%100.34%
Return on Assets (ROA)
-5.74%-5.74%-55.15%-109.29%-90.52%
Return on Equity (ROE)
-10.01%-7.39%-96.84%-142.12%-112.82%
Return on Capital Employed (ROCE)
-10.54%-7.76%-85.18%-145.28%-115.76%
Return on Invested Capital (ROIC)
-10.05%-7.48%-67.63%-132.92%-108.23%
Return on Tangible Assets
-8.88%-8.88%-160.87%-149.70%-113.55%
Earnings Yield
-2.76%-1.82%-17.15%-13.77%-8.80%
Efficiency Ratios
Receivables Turnover
 3.29 3.29 3.54 161.83 5.79
Payables Turnover
 3.76 3.76 1.87 0.24 0.41
Inventory Turnover
 2.42 2.42 1.11 1.40 0.24
Fixed Asset Turnover
 6.37 6.37 10.39 0.76 0.59
Asset Turnover
 0.38 0.38 0.23 0.05 0.02
Working Capital Turnover Ratio
 1.37 1.68 2.29 0.09 0.02
Cash Conversion Cycle
 165.22 165.23 235.87 -1.25K 682.74
Days of Sales Outstanding
 111.05 111.06 103.00 2.26 62.99
Days of Inventory Outstanding
 151.12 151.12 328.05 260.87 1.52K
Days of Payables Outstanding
 96.95 96.95 195.17 1.51K 900.72
Operating Cycle
 262.17 262.18 431.04 263.13 1.58K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.01 -0.02 -0.02
Free Cash Flow Per Share
 >-0.01 >-0.01 -0.02 -0.02 -0.02
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.07 1.06 1.04
Dividend Paid and CapEx Coverage Ratio
 -206.14 -206.14 -13.76 -16.00 -27.61
Capital Expenditure Coverage Ratio
 -206.14 -206.14 -13.76 -16.00 -27.61
Operating Cash Flow Coverage Ratio
 -1.31 -1.31 -3.33 -26.28 -20.91
Operating Cash Flow to Sales Ratio
 -0.28 -0.28 -2.26 -20.03 -35.75
Free Cash Flow Yield
-5.16%-3.41%-17.44%-13.65%-8.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -36.24 -54.98 -5.83 -7.26 -11.37
Price-to-Sales (P/S) Ratio
 5.45 8.25 13.87 155.91 424.66
Price-to-Book (P/B) Ratio
 2.68 4.06 5.65 10.32 12.83
Price-to-Free Cash Flow (P/FCF) Ratio
 -19.37 -29.35 -5.73 -7.33 -11.46
Price-to-Operating Cash Flow Ratio
 -19.44 -29.49 -6.15 -7.78 -11.88
Price-to-Earnings Growth (PEG) Ratio
 -0.49 0.69 0.56 2.15 -0.14
Price-to-Fair Value
 2.68 4.06 5.65 10.32 12.83
Enterprise Value Multiple
 -96.25 -175.51 -6.17 -6.56 -10.19
Enterprise Value
 21.48M 34.50M 16.78M 19.38M 30.07M
EV to EBITDA
 -96.25 -175.51 -6.17 -6.56 -10.19
EV to Sales
 4.63 7.44 13.88 146.74 402.23
EV to Free Cash Flow
 -16.47 -26.45 -5.74 -6.90 -10.86
EV to Operating Cash Flow
 -16.55 -26.57 -6.16 -7.33 -11.25
Tangible Book Value Per Share
 0.02 0.02 >-0.01 <0.01 0.01
Shareholders’ Equity Per Share
 0.04 0.04 0.02 0.01 0.02
Tax and Other Ratios
Effective Tax Rate
 0.03 0.03 0.02 0.06 0.07
Revenue Per Share
 0.02 0.02 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 -0.02 -0.02 -0.02
Tax Burden
 0.97 0.97 0.98 0.94 0.93
Interest Burden
 1.15 1.15 1.02 1.00 1.00
Research & Development to Revenue
 0.03 0.03 0.47 7.05 11.52
SG&A to Revenue
 0.08 0.08 0.06 0.28 0.38
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 0.70
Income Quality
 1.86 1.82 0.92 0.93 0.96
Currency in GBP